Likewise, Goka et al. later demonstrated that CRC cells (i.e., HT116 and HT29) up-regulated RAC1b expression upon chemotherapy treatment, thereby promoting NF-κB pathway and cell survival gene transcription [55]. This evidence concerns the gene NFKB1 and colorectal carcinoma.